News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
336,258 Results
Type
Article (12039)
Company Profile (62)
Press Release (324149)
Multimedia
Podcasts (15)
Webinars (9)
Section
Business (108427)
Career Advice (671)
Deals (17856)
Drug Delivery (28)
Drug Development (35315)
Employer Resources (57)
FDA (5641)
Job Trends (6571)
News (167278)
Policy (11562)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1125)
Accelerated approval (11)
Adcomms (7)
Allergies (55)
Alliances (23360)
ALS (89)
Alzheimer's disease (815)
Antibody-drug conjugate (ADC) (118)
Approvals (5808)
Artificial intelligence (238)
Autoimmune disease (68)
Automation (19)
Bankruptcy (121)
Best Places to Work (5271)
BIOSECURE Act (1)
Biosimilars (65)
Biotechnology (45)
Bladder cancer (73)
Brain cancer (23)
Breast cancer (282)
Cancer (2115)
Cardiovascular disease (210)
Career advice (588)
Career pathing (14)
CAR-T (123)
CDC (11)
Cell therapy (330)
Cervical cancer (10)
Clinical research (30081)
Collaboration (838)
Compensation (422)
Complete response letters (13)
COVID-19 (992)
CRISPR (51)
C-suite (562)
Cystic fibrosis (71)
Data (3133)
Denatured (7)
Depression (58)
Diabetes (208)
Diagnostics (3268)
Digital health (16)
Diversity (4)
Diversity, equity & inclusion (19)
Drug discovery (124)
Drug pricing (29)
Drug shortages (4)
Duchenne muscular dystrophy (101)
Earnings (47535)
Editorial (19)
Employer branding (10)
Employer resources (56)
Events (56383)
Executive appointments (637)
FDA (6983)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (14)
Funding (753)
Gene editing (87)
Generative AI (21)
Gene therapy (255)
GLP-1 (351)
Government (1285)
Grass and pollen (1)
Guidances (234)
Healthcare (7905)
HIV (36)
Huntington's disease (13)
IgA nephropathy (33)
Immunology and inflammation (82)
Immuno-oncology (22)
Indications (44)
Infectious disease (1089)
Inflammatory bowel disease (93)
Inflation Reduction Act (3)
Influenza (38)
Intellectual property (81)
Interviews (84)
IPO (8835)
IRA (10)
Job creations (1527)
Job search strategy (530)
JPM (19)
Kidney cancer (12)
Labor market (21)
Layoffs (178)
Leadership (10)
Legal (2928)
Liver cancer (39)
Longevity (7)
Lung cancer (260)
Lymphoma (151)
Machine learning (23)
Management (19)
Manufacturing (305)
MASH (81)
Medical device (5270)
Medtech (5288)
Mergers & acquisitions (9578)
Metabolic disorders (519)
Multiple sclerosis (64)
NASH (6)
Neurodegenerative disease (152)
Neuropsychiatric disorders (37)
Neuroscience (1405)
Neurotech (1)
NextGen: Class of 2026 (2650)
Non-profit (1949)
Now hiring (15)
Obesity (222)
Opinion (101)
Ovarian cancer (63)
Pain (73)
Pancreatic cancer (84)
Parkinson's disease (140)
Partnered (15)
Patents (131)
Patient recruitment (208)
Peanut (18)
People (37013)
Pharmaceutical (15)
Pharmacy benefit managers (3)
Phase 1 (8992)
Phase 2 (12885)
Phase 3 (10516)
Pipeline (2977)
Policy (74)
Postmarket research (1088)
Preclinical (4654)
Press Release (69)
Prostate cancer (117)
Psychedelics (19)
Radiopharmaceuticals (155)
Rare diseases (380)
Real estate (2749)
Recruiting (21)
Regulatory (9040)
Reports (19)
Research institute (1218)
Resumes & cover letters (91)
Rett syndrome (23)
RNA editing (5)
RSV (16)
Schizophrenia (79)
Series A (140)
Series B (83)
Sickle cell disease (44)
Special edition (2)
Spinal muscular atrophy (90)
Sponsored (20)
Startups (1848)
State (1)
Stomach cancer (4)
Supply chain (29)
Tariffs (13)
The Weekly (8)
Vaccines (305)
Venture capital (31)
Weight loss (99)
Women's health (36)
Worklife (2)
Date
Last 7 days (329)
Last 30 days (998)
Last 365 days (14952)
2026 (1722)
2025 (14967)
2024 (17277)
2023 (20110)
2022 (26818)
2021 (28920)
2020 (26644)
2019 (20541)
2018 (15820)
2017 (15760)
2016 (14731)
2015 (17940)
2014 (13793)
2013 (10950)
2012 (11605)
2011 (12284)
2010 (11593)
Location
Africa (316)
Alabama (32)
Alaska (5)
Arizona (116)
Arkansas (3)
Asia (17596)
Australia (2784)
California (5478)
Canada (1777)
China (405)
Colorado (246)
Connecticut (254)
Delaware (143)
Europe (42149)
Florida (783)
Georgia (143)
Hawaii (1)
Idaho (30)
Illinois (317)
India (26)
Indiana (198)
Iowa (13)
Japan (249)
Kansas (50)
Kentucky (21)
Louisiana (15)
Maine (54)
Maryland (597)
Massachusetts (4466)
Michigan (202)
Minnesota (260)
Mississippi (3)
Missouri (69)
Montana (19)
Nebraska (17)
Nevada (63)
New Hampshire (27)
New Jersey (1543)
New Mexico (22)
New York (1481)
North Carolina (743)
North Dakota (5)
Northern California (2744)
Ohio (200)
Oklahoma (10)
Oregon (25)
Pennsylvania (1053)
Puerto Rico (6)
Rhode Island (32)
South America (431)
South Carolina (21)
Southern California (2131)
Tennessee (90)
Texas (855)
United States (19879)
Utah (199)
Vermont (1)
Virginia (127)
Washington D.C. (28)
Washington State (467)
West Virginia (3)
Wisconsin (87)
Wyoming (1)
336,258 Results for "kewaunee scientific corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026
November 27, 2025
·
4 min read
Press Releases
Kewaunee Scientific Announces Appointment of J. Jette Campbell to Board of Directors
September 12, 2025
·
5 min read
Press Releases
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2026
September 10, 2025
·
14 min read
Press Releases
Kewaunee Scientific to Report Results for First Quarter Fiscal Year 2026
August 28, 2025
·
4 min read
Press Releases
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
June 26, 2025
·
24 min read
Press Releases
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter
June 12, 2025
·
4 min read
Business
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter 2024
Kewaunee Scientific Corporation announced results for its fourth quarter and its fiscal year ended April 30, 2024.
June 26, 2024
·
21 min read
Press Releases
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
November 4, 2024
·
7 min read
Business
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024
Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2024.
March 6, 2024
·
11 min read
Press Releases
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
March 13, 2025
·
18 min read
1 of 33,626
Next
